Consensus recommendations for botulinum toxin injections in the spasticity management of children with cerebral palsy during COVID-19 outbreak

dc.contributor.authorYilmaz Yalçinkaya E.
dc.contributor.authorKaradağ Saygi E.
dc.contributor.authorTaskiran Ö.Ö.
dc.contributor.authorÇapan N.
dc.contributor.authorKutlay Ş.
dc.contributor.authorSonel Tur B.
dc.contributor.authorEl Ö.
dc.contributor.authorAkyüz E.Ü.
dc.contributor.authorTekın S.
dc.contributor.authorOfluoğlu D.
dc.contributor.authorZinnuroğlu M.
dc.contributor.authorAkpinar P.
dc.contributor.authorÖzeklı Misirlioğlu T.
dc.contributor.authorHüner B.
dc.contributor.authorNur H.
dc.contributor.authorÇağlar S.
dc.contributor.authorSezgın M.
dc.contributor.authorTikiz C.
dc.contributor.authorÖneş K.
dc.contributor.authorİçağasioğlu A.
dc.contributor.authorAydin R.
dc.date.accessioned2024-07-22T08:06:34Z
dc.date.available2024-07-22T08:06:34Z
dc.date.issued2021
dc.description.abstractSpasticity is the most common motor disturbance in cerebral palsy (CP). Lockdown in the COVID-19 outbreak has profoundly changed daily routines, and similarly caused the suspension of spasticity treatment plans. Besides, the delay in botulinum toxin (BoNT) injection, which is important in the management of focal spasticity, led to some problems in children. This consensus report includes BoNT injection recommendations in the management of spasticity during the COVID-19 pandemic in children with CP. In order to develop the consensus report, physical medicine and rehabilitation (PMR) specialists experienced in the field of pediatric rehabilitation and BoNT injections were invited by Pediatric Rehabilitation Association. Items were prepared and adapted to the Delphi technique by PMR specialists. Then they were asked to the physicians experienced in BoNT injections (PMR specialist, pediatric orthopedists, and pediatric neurologists) or COVID-19 (pediatric infectious disease, adult infectious disease). In conclusion, the experts agree that conservative management approaches for spasticity may be the initial steps before BoNT injections. BoNT injections can be administered to children with CP with appropriate indications and with necessary precautions during the pandemic. © TÜBİTAK.
dc.identifier.DOI-ID10.3906/sag-2009-5
dc.identifier.issn13000144
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13578
dc.language.isoEnglish
dc.publisherTurkiye Klinikleri
dc.rightsAll Open Access; Hybrid Gold Open Access
dc.subjectAcetylcholine Release Inhibitors
dc.subjectBotulinum Toxins
dc.subjectCerebral Palsy
dc.subjectChild
dc.subjectCommunicable Disease Control
dc.subjectCOVID-19
dc.subjectDelphi Technique
dc.subjectHumans
dc.subjectInfection Control
dc.subjectInjections, Intramuscular
dc.subjectMuscle Spasticity
dc.subjectPractice Guidelines as Topic
dc.subjectSARS-CoV-2
dc.subjectbotulinum toxin
dc.subjectacetylcholine release inhibitor
dc.subjectbotulinum toxin
dc.subjectArticle
dc.subjectcerebral palsy
dc.subjectchild
dc.subjectcomputer assisted tomography
dc.subjectcontact examination
dc.subjectcoronavirus disease 2019
dc.subjectdaily life activity
dc.subjectDelphi study
dc.subjectdisinfection
dc.subjectelectromyography
dc.subjectfollow up
dc.subjecthuman
dc.subjectinfection risk
dc.subjectmotor dysfunction
dc.subjectpandemic
dc.subjectpediatric rehabilitation
dc.subjectphysical disability
dc.subjectprevalence
dc.subjectreal time reverse transcription polymerase chain reaction
dc.subjectrehabilitation medicine
dc.subjectspasticity
dc.subjecttelemedicine
dc.subjectvaccination
dc.subjectvirus transmission
dc.subjectcerebral palsy
dc.subjectcommunicable disease control
dc.subjectconsensus development
dc.subjectinfection control
dc.subjectintramuscular drug administration
dc.subjectpathophysiology
dc.subjectpractice guideline
dc.subjectprevention and control
dc.subjectprocedures
dc.subjectspasticity
dc.titleConsensus recommendations for botulinum toxin injections in the spasticity management of children with cerebral palsy during COVID-19 outbreak
dc.typeArticle

Files